European Union

The European Union’s highest court has ruled that CBD is not a narcotic because it does not have any psychotropic or harmful effects.

Recent polling shows 65 percent of Ukraine voters support legalizing medical cannabis access for severely ill patients.

The EU Parliament has voted to raise THC limits for industrial hemp from 0.2 to 0.3 percent and to establish hemp industry marketing standards.

Canada’s MediPharm and European pharmaceutical firm STADA have signed an exclusive supply agreement for the distribution of medical cannabis products in Germany.

The island nation of Malta has officially run out of cannabis, both for medical patients and on the unregulated marketplace.

The European Commission is considering labeling foods that contain hemp-derived CBD as “narcotic-related.” In the meantime, the commission has suspended applications for novel food products containing non-synthetic CBD.

A European Court of Justice magistrate has ruled that EU member states cannot ban imported CBD products because the law does not consider the cannabinoid to be a narcotic drug.

A Croatian lawmaker has proposed adult-use legalization legislation; if successful, Croatia would be the first European Union member to fully legalize adult-use cannabis.

The mayor of Amsterdam is considering banning tourists from buying cannabis in a reported effort to clean up the city’s overcrowded red-light district.

An EU court has ruled against the Cannabis Store Amsterdam’s attempts to register a trademark because it is “contrary to public policy,” according to the court.

Regulators in the UK have banned a $2.56 million ad campaign for Dead Man’s Fingers, a hemp CBD-infused rum product from Cornish Rum Company that leaned on cannabis innuendos in its marketing strategies.

A new experimental cannabis marketplace in The Netherlands will require all distributed cannabis products to utilize plain white, “unattractive” packaging that includes health warnings and only black Helvetica font.

The European Union has approved Epidiolex for the treatment of two childhood epilepsy conditions. It’s the first time the EU has approved a cannabis-based medication.

A medical cannabis product shipment by Industrial Globus Uganda Ltd. has been approved by European Union inspectors; the shipment contains THC- and CBD-rich cannabis meant for Sativex drug production.

Luxembourg officials say they plan to legalize adult-use cannabis and regulate its production and distribution within the next two years.

The European Union’s Parliament has rallied alongside the United Nations’ World Health Organization in recommending an end to cannabis prohibition.

CBD content in European cannabis products, however, has not risen alongside its psychoactive counterpart.